Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Positioning and omeprazole/placebo for infant gastroesophageal reflux disease
ACTRN12609000988257Phase 3Recruiting
- Sponsor
- Women's and Children's Health Network
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of omeprazole in gastroesophageal reflux disease (GERD) (4 arms), sponsored by Women's and Children's Health Network. Primary endpoint: Number of gastroesophageal reflux episodes. Started Jul 2008; status: recruiting.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ACTRN12609000988257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000988257.